Cryle Laboratory
Reengineering Glycopeptide Antibiotics
Welcome to the Cryle Lab
My group focus on antibiotic discovery: specifically, how to make new antibiotics to overcome the severe threat posed to modern medicine by antimicrobial resistance (e.g. MRSA).
We're part of the Monash Biomedicine Discovery Institute, and a member of the Infection & Immunity Program and the Department of Biochemistry and Molecular Biology.
Associate Professor Max Cryle
My global research connections, partners and funding can be viewed on my Monash Research Profile.
If you are a student interested in doing research in our lab, visit Supervisor Connect.
Click the links below to connect with me on ORCID, Google Scholar and LinkedIn.
Our research
We focus on antibiotics: understanding how these compounds are made in nature, how we can re-engineer these natural systems to produce new antibiotics as well as developing novel approaches to treat bacterial infections. Given the importance of antibiotics for human health, our ultimate goal is to develop novel antibiotic therapies that we so badly need to deal with serious bacterial infections and the threat posed by antimicrobial resistance.
1. Exploiting biocatalysis and chemical synthesis to generate new antibiotics
2. Redesigning antibiotic biosynthesis to enable production of modified antibiotics
3. Overcoming antimicrobial resistance by exploiting novel strategies to kill superbugs
Lab members
We are committed to excellence in research.
Join Our Lab
We're always interested in collaborating with bright and motivated researchers, clinicians and industry. Whether you want to research, study or partner with us to accelerate our discoveries, find out about the work we do.